Neuroprotective effect of resveratrol on arsenic trioxide-induced oxidative stress in feline brain

Human and Experimental Toxicology

Volumn 33, Issue 7, 2014, Pages 737-747

  Cheng, Y ^a   Xue, J ^b   Jiang, H ^a   Wang, M ^a   Gao, L ^a   Ma, D ^a   Zhang, Z ^a  

^a NORTHEAST AGRICULTURAL UNIVERSITY   (China)

^b INNER MONGOLIA UNIVERSITY FOR NATIONALITIES   (China)

Author keywords

Arsenic trioxide; brain; neuroprotective effect; oxidative damage; resveratrol

Indexed keywords

ARSENIC TRIOXIDE; CATALASE; GLUTATHIONE; MALONALDEHYDE; REACTIVE OXYGEN METABOLITE; RESVERATROL; SODIUM CHLORIDE; SUPEROXIDE DISMUTASE; ANTINEOPLASTIC AGENT; ANTIOXIDANT; NEUROPROTECTIVE AGENT; ORGANOARSENIC DERIVATIVE; OXIDE; POLLUTANT; STILBENE DERIVATIVE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; BRAIN INJURY; CAT; CELL STRUCTURE; COMPARATIVE STUDY; CONTROLLED STUDY; DIARRHEA; DISEASE SEVERITY; DROWSINESS; DRUG EFFECT; ENZYME ACTIVITY; FEMALE; HISTOPATHOLOGY; HYPERPIGMENTATION; MALE; NERVE CELL; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; SKIN PRURITUS; UPREGULATION; VOMITING; ANIMAL; CELL PROTECTION; DRUG EFFECTS; ENZYMOLOGY; METABOLISM; POLLUTANT; TOXICITY;

ANIMALS; ANTINEOPLASTIC AGENTS; ANTIOXIDANTS; ARSENICALS; CATS; CEREBRAL CORTEX; CYTOPROTECTION; ENVIRONMENTAL POLLUTANTS; FEMALE; GLUTATHIONE; MALE; MALONDIALDEHYDE; NEUROPROTECTIVE AGENTS; OXIDATIVE STRESS; OXIDES; REACTIVE OXYGEN SPECIES; STILBENES;

EID: 84903471531     PISSN: 09603271     EISSN: 14770903     Source Type: Journal    
DOI: 10.1177/0960327113506235     Document Type: Article

References (62)

1. Chakraborti D, Rahman MM, Paul K, Chowdhury UK, Sengupta MK, Lodh D, et al. Arsenic calamity in the Indian subcontinent: what lessons have been learned?. Talanta. 2002 ; 58: 3-22
2. Rana T, Bera AK, Das S, Bhattacharya D, Pan D, Bandyopadhyay S, et al. Mushroom lectin protects arsenic induced apoptosis in hepatocytes of rodents. Hum Exp Toxicol. 2011 ; 30: 307-317
3. Rana T, Bera AK, Das S, Pan D, Bandyopadhyay S, Bhattacharya D, et al. Supplementation of ascorbic acid prevents oxidative damages in arsenic-loaded hepatic tissue of rat: an ex vivo study. Hum Exp Toxicol. 2010 ; 29: 965-972
4. Halatek T, Sinczuk Walczak H, Rabieh S, Wasowicz W. Association between occupational exposure to arsenic and neurological, respiratory and renal effects. Toxicol Appl Pharmaco. 2009 ; 239: 193-199
5. Mathew L, Vale A, Adcock JE. Arsenical peripheral neuropathy. Pract Neurol. 2010 ; 10: 34-38
6. Flora SJ, Bhatt K, Mehta A. Arsenic moiety in gallium arsenide is responsible for neuronal apoptosis and behavioral alterations in rats. Toxicol Appl Pharmacol. 2009 ; 240: 236-244
7. Ríos R, Zarazúa S, Santoyo ME, Sepúlveda-Saavedra J, Romero-Díaz V, Jiménez V, et al. Decreased nitric oxide markers and morphological changes in the brain of arsenic-exposed rats. Toxicology. 2009 ; 261: 68-75
8. Tripathi N, Kannan GM, Pant BP, Jaiswal DK, Malhotra PR, Flora SJ. Arsenic-induced changes in certain neurotransmitter levels and their recoveries following chelation in rat whole brain. Toxicol Lett. 1997 ; 92: 201-208
9. Itoh T, Zhang YF, Murai S, Saito H, Nagahama H, Miyate H, et al. The effect of arsenic trioxide on brain monoamine metabolism and locomotor activity of mice. Toxicol Lett. 1990 ; 54: 345-353
10. Miller WH, Schipper HM, Lee JS, Singer J, Waxman S. Mechanisms of action of arsenic trioxide. Canc Res. 2002 ; 62: 3893-3903
11. Chen SJ, Zhou GB, Zhang XW, Mao JH, de Thé H, Chen Z. From an old remedy to a magic bullet: molecular mechanisms underlying the therapeutic effects of arsenic in fighting leukemia. Blood. 2011 ; 117: 6425-6437
12. Soignet SL, Frankel SR, Douer D, Tallman MS, Kantarjian H, Calleja E, et al. United states multicenter study of arsenic trioxide in relapsed acute promyelocytic leukemia. J Clin Oncol. 2001 ; 19: 3852-3860
13. Messarah M, Saoudi M, Boumendjel A, Kadeche L, Boulakoud MS, Feki AE. Green tea extract alleviates arsenic-induced biochemical toxicity and lipid peroxidation in rats. Toxicol Ind Health. 2013 ; 29: 349-359
14. El-Agamy DS. Comparative effects of curcumin and resveratrol on aflatoxin B (1)-induced liver injury in rats. Arch Toxicol. 2010 ; 84: 389-396
15. Malhotra A, Nair P, Dhawan DK. Curcumin and resveratrol in combination modulates benzo (a) pyrene-induced genotoxicity during lung carcinogenesis. Hum Exp Toxicol. 2012 ; 31: 1199-1206
16. Zhao XY, Li GY, Liu Y, Chai LM, Chen JX, Zhang Y, et al. Resveratrol protects against arsenic trioxide-induced cardiotoxicity in vitro and in vivo. Br J Pharmacol. 2008 ; 154: 105-113
17. Nicolini G, Rigolio R, Scuteri A, Miloso M, Saccomanno D, Cavaletti G, et al. Effect of trans-resveratrol on signal transduction pathways involved in paclitaxel-induced apoptosis in human neuroblastoma SH-SY5Y cells. Neurochem Int. 2003 ; 42: 419-429
18. Yousuf S, Atif F, Ahmad M, Hoda N, Ishrat T, Khan B, et al. Resveratrol exerts its neuroprotective effect by modulating mitochondrial dysfunctions and associated cell death during cerebral ischemia. Brain Res. 2009 ; 1250: 242-253
19. Li Z, Pang L, Fang F, Zhang G, Zhang J, Xie M, et al. Resveratrol attenuates brain damage in a rat model of focal cerebral ischemia via up-regulation of hippocampal Bcl-2. Brain Res. 2012 ; 1450: 116-124
20. Baur JA, Sinclair DA. Therapeutic potential of resveratrol: the in vivo evidence. Nat Rev Drug Discov. 2006 ; 5: 493-506
21. Das DK, Maulik N. Resveratrol in cardioprotection: a therapeutic promise of alternative medicine. Mol Interv. 2006 ; 6: 36-47
22. Duraj J, Bodo J, Sulikova M, Rauko P, Sedlak J. Diverse resveratrol sensitization to apoptosis induced by anticancer drugs in sensitive and resistant leukemia cells. Neoplasma. 2006 ; 53: 384-392
23. El-Demerdash FM. Yousef MI and Radwan FM. Ameliorating effect of curcumin on sodium arsenite-induced oxidative damage and lipid peroxidation in different rat organs. Food Chem Toxicol. 2009 ; 47: 249-254
24. Giraudel JM, Diquelou A, Laroute V, Lees P, Toutain PL. Pharmacokinetic/pharmacodynamic modelling of NSAIDs in a model of reversible inflammation in the cat. Br J Pharmacol. 2005 ; 146: 642-653
25. Rezk YA, Balulad SS, Keller RS, Bennett JA. Use of resveratrol to improve the effectiveness of cisplatin and doxorubicin: study in human gynecologic cancer cell lines and in rodent heart. Am J Obstet Gynecol. 2006 ; 194: e23 - e26
26. Huang TC, Lu KT, Wo YY, Wu YJ, Yang YL. Resveratrol protects rats from A-induced neurotoxicity by the reduction of iNOS expression and lipid peroxidation. PLoS One. 2011 ; 6: e29102
27. Liu H, Zhang X, Du Y, Ji H, Li S, Li L, et al. Leonurine protects brain injury by increased activities of UCP4, SOD, CAT and Bcl-2, decreased levels of MDA and Bax, and ameliorated ultrastructure of mitochondria in experimental stroke. Brain Res. 2012 ; 1474: 73-81
28. Socci DJ, Bjugstad KB, Jones HC, Pattisapu JV, Arendash GW. Evidence that oxidative stress is associated with the pathophysiology of inherited hydrocephalus in the H-Tx rat model. Exp Neurol. 1999 ; 155: 109-117
29. Cui X, Kobayashi Y, Hayakawa T, Hirano S. Arsenic speciation in bile and urine following oral and intravenous exposure to inorganic and organic arsenics in rats. Toxicol Sci. 2004 ; 82: 478-487
30. Yadav RS, Shukla RK, Sankhwar ML, Patel DK, Ansari RW, Pant AB, et al. Neuroprotective effect of curcumin in arsenic-induced neurotoxicity in rats. Neurotoxicology. 2010 ; 31: 533-539
31. Das AK, Bag S, Sahu R, Dua TK, Sinha MK, Gangopadhyay M, et al. Protective effect of Corchorus olitorius leaves on sodium arsenite-induced toxicity in experimental rats. Food Chem Toxicol. 2010 ; 48: 326-335
32. Halliwell B, Whiteman M. Measuring reactive species and oxidative damage in vivo and in cell culture: how should you do it and what do the results mean?. Br J Pharmacol. 2004 ; 142: 231-255
33. Lyn S, Gurr JR, Lai HT, Jan KY. NADH oxidase activation is involved in arsenite-induced oxidative DNA damage in human vascular smooth muscle cells. Circ Res. 2000 ; 86: 514-519
34. Flora SJ, Bhatt K, Mehta A. Arsenic moiety in gallium arsenide is responsible for neuronal apoptosis and behavioral alterations in rats. Toxicol Appl Pharmacol. 2009 ; 240: 236-244
35. Chattopadhyay S, Bhaumik S, Nag Chaudhury A, Das Gupta S. Arsenic-induced changes in growth development and apoptosis in neonatal and adult brain cells in vivo and in tissue culture. Toxicol Lett. 2002 ; 128: 73-84
36. Naranmandura H, Xu S, Sawata T, Hao WH, Liu H, Bu N, et al. Mitochondria are the main target organelle for trivalent monomethylarsonous acid (MMAIII)-induced cytotoxicity. Chem Res Toxicol. 2011 ; 24: 1094-1103
37. Li F, Gong Q, Dong H, Shi J. Resveratrol, a neuroprotective supplement for Alzheimer's disease. Curr Pharm Des. 2012 ; 18: 27-33
38. Han YS, Zheng WH, Bastianetto S, Chabot JG, Quirion R. Neuroprotective effects of resveratrol against beta-amyloid-induced neurotoxicity in rat hippocampal neurons: involvement of protein kinase C. Br J Pharmacol. 2004 ; 141: 997-1005
39. Zheng J, Chen LL, Zhang HH, Hu X, Kong W, Hu D. Resveratrol improves insulin resistance of catch-up growth by increasing mitochondrial complexes and antioxidant function in skeletal muscle. Metabolism. 2012 ; 61: 954-965
40. Dolinsky VW, Chan AY, Robillard Frayne I, Light PE, Des Rosiers C, Dyck JR. Resveratrol prevents the prohypertrophic effects of oxidative stress on LKB1. Circulation. 2009 ; 119: 1643-1652
41. Nordenson I, Beckman L. Is the genotoxic effect of arsenic mediated by oxygen free-radicals?. Hum Hered. 1991 ; 41: 71-73
42. Wang TS, Huang H. Active oxygen species are involved in the induction of micronuclei by arsenite in XRS-5 cells. Mutagenesis. 1994 ; 9: 253-257
43. Pari L, Amali DR. Protective role of tetrahydrocurcumin (THC) an active principle of turmeric on chloroquine induced hepatotoxicity in rats. J Pharm Pharm Sci. 2005 ; 8: 115-123
44. Yen GC, Duh PD, Lin CW. Effects of resveratrol and 4-hexylresorcinol on hydrogen peroxide-induced oxidative DNA damage in human lymphocytes. Free Radic Res. 2003 ; 37: 509-514
45. Ates O, Cayli SR, Yucel N, Altinoz E, Kocak A, Durak MA, et al. Central nervous system protection by resveratrol in streptozotocin-induced diabetic rats. J Clin Neurosci. 2007 ; 14: 256-260
46. Park SJ, Ahmad F, Philp A, Baar K, Williams T, Luo H, et al. Resveratrol ameliorates aging-related metabolic phenotypes by inhibiting cAMP phosphodiesterases. Cell. 2012 ; 148: 421-433
47. St-Pierre J, Drori S, Uldry M, Silvaggi JM, Rhee J, Jäger S. Suppression of reactive oxygen species and neurodegeneration by the PGC-1 transcriptional coactivators. Cell. 2006 ; 127: 397-408
48. Yamanaka K, Hasegawa A, Sawamura R, Okada S. Cellular response to oxidative damage in lung induced by the administration of dimethylarsinic acid, a major metabolite of inorganic arsenics, in mice. Toxicol Appl Pharmacol. 1991 ; 108: 205-213
49. Radabaugh TR, Aposhian HV. Enzymatic reduction of arsenic compounds in mammalian system: reduction of arsenate to arsenite by human liver arsenate reductase. Chem Res Toxicol. 2000 ; 13: 26-30
50. Juan SH, Cheng TH, Lin HC, Chu YL, Lee WS. Mechanism of concentration-dependent induction of heme oxygenase-1 by resveratrol in human aortic smooth muscle cells. Biochem Pharmacol. 2005 ; 69: 41-48
51. Yilmaz O, Keser S, Tuzcu M, Cetinta B. Resveratrol (trans-3,4,5- trihydroxystilbene) decreases lipid peroxidation level and protects antioxidant capacity in sera and erythrocytes of old female Wistar rats induced by the kidney carcinogen potassium bromate. Environ Toxicol Pharmacol. 2007 ; 24: 79-85
52. Hassan-Khabbar S, Cottart CH, Wendum D, Vibert F, Clot JP, Savouret JF. Postischemic treatment by trans-resveratrol in rat liver ischemia-reperfusion: a possible strategy in liver surgery. Liver Transpl. 2008 ; 14: 451-459
53. Leelank BN, Bansal MP. Effect of selenium supplementation on the glutathione redox system in the kidney of mice after chronic cadmium exposures. J Appl Toxicol. 1996 ; 17: 81-84
54. Wirtitsch M, Roth E, Bachleitner-Hofmann T, Wessner B, Sturlan S. Omega 3 and omega 6 polyunsaturated fatty acids enhance arsenic trioxide efficacy in arsenic trioxide resistant leukemic and solid tumor cells. Oncol Res. 2009 ; 18: 83-94
55. Yadav RS, Sankhwar ML, Shukla RK, Chandra R, Pant AB, Islam F, et al. Attenuation of arsenic neurotoxicity by curcumin in rats. Toxicol Appl Pharmacol. 2009 ; 240: 367-376
56. Brazy PC, Balaban RS, Gullans SR, Mandel LJ, Dennis VW. Inhibition of renal metabolism. Relative effects of arsenate on sodium, phosphate, and glucose transport by the rabbit proximal tubule. J Clin Invest. 1980 ; 66: 1211-1221
57. Bergquist ER, Fischer RJ, Sugden KD, Martin BD. Inhibition by methylated organo-arsenicals of the respiratory 2-oxo-acid dehydrogenases. J Organomet Chem. 2009 ; 694: 973-980
58. Lagouge M, Argmann C, Gerhart-Hines Z, Meziane H, Lerin C, Daussin F, et al. Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1. Cell. 2006 ; 127: 1109-1122
59. Sakurai T, Kojima C, Kobayashi Y, Hirano S, Sakurai MH, Waalkes MP, et al. Toxicity of a trivalent organic arsenic compound, dimethylarsinous glutathione in a rat liver cell line (TRL 1215). Br J Pharmacol. 2006 ; 149: 888-897
60. Williams LD, Burdock GA, Edwards JA, Beck M, Bausch J. Safety studies conducted on high-purity trans-resveratrol in experimental animals. Food Chem Toxicol. 2009 ; 47: 2170-2182
61. Shila S, Subathra M, Devi MA, Panneerselvam C. Arsenic intoxication-induced reduction of glutathione level and of the activity of related enzymes in rat brain regions: reversal by DL-lipoic acid. Arch Toxicol. 2005 ; 79: 140-146
62. Gharibzadeh S, Hoseini SS. Arsenic exposure may be a risk factor for Alzheimer's disease. J Neuropsych Clin Neurosci. 2008 ; 20: 501